malondialdehyde has been researched along with Multiple Sclerosis, Relapsing-Remitting in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bapir, AA; Hamad, MS; Iqbal, ZM; Ismaeal, YS; Kaleem, M; Khudhur, ZO; Mohammad, KA; Omar, SA; Qadir, MK; Qureshi, AS; Rajab, MF; Rasoul, AA; Rasul, MF; Rizwan, MA; Salihi, A; Smail, SW | 1 |
| Abdelghani, AA; Elsharkawi, KA; Ghonimi, NAM; Khyal, DSM | 1 |
| Adamczyk, B; Adamczyk-Sowa, M; Kasperczyk, S; Wawrzyniak, S | 1 |
| Akbari, M; Asadikaram, G; Ebrahimi, G; Juybari, KB; Karimi, A; Mirzamohammadi, S; Momeni Moghaddam, MA; Nematollahi, MH; Torkzadeh-Mahani, M | 1 |
| Cvetkovic, T; Kocic, G; Ljubisavljevic, S; Pavlovic, D; Savic, D; Stojanov, D; Stojanovic, I; Stojanovic, S; Vojinovic, S | 1 |
| Cvetkovic, T; Ljubisavljevic, S; Pavlovic, D; Stefanovic, N; Stojanov, D; Stojanovic, D; Stojanovic, I; Vojinovic, S | 1 |
| Bartova, R; Durfinova, M; Liska, B; Oresanska, K; Petrlenicova, D; Prochazkova, L; Turecky, L | 1 |
| Aguayo, A; Barba, EA; Cruz-Ramos, JA; Macías-Islas, MA; Ortiz, GG; Pacheco-Moisés, FP; Sustersik, S | 1 |
| Bisaga, GN; Odinak, MM; Zarubina, IV | 1 |
2 trial(s) available for malondialdehyde and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.
Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunomodulation; Immunosuppressive Agents; Lipid Peroxides; Lipofuscin; Male; Malondialdehyde; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Oxidative Stress | 2017 |
[New approaches to antioxidant therapy in multiple sclerosis].
Topics: Adult; Antioxidants; Female; Glutathione; Glutathione Reductase; Humans; Male; Malondialdehyde; Multiple Sclerosis, Relapsing-Remitting; NADP; Superoxide Dismutase | 2002 |
7 other study(ies) available for malondialdehyde and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population.
Topics: Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress | 2021 |
Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics.
Topics: Case-Control Studies; Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2021 |
Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
Topics: Adult; Arsenic; Case-Control Studies; Female; Humans; Lactic Acid; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Reactive Oxygen Species | 2018 |
Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.
Topics: Acute Disease; Adolescent; Adult; Biomarkers; Catalase; Demography; Female; Humans; Magnetic Resonance Imaging; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Phenotype; Superoxide Dismutase; Young Adult | 2013 |
Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Topics: Adolescent; Adult; Advanced Oxidation Protein Products; Blood Cell Count; Cross-Sectional Studies; Disability Evaluation; Erythrocytes; Female; Humans; Magnetic Resonance Imaging; Male; Malondialdehyde; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neurodegenerative Diseases; Oxidative Stress; Superoxide Dismutase; Young Adult | 2014 |
Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Biomarkers; Disease Progression; F2-Isoprostanes; Humans; Lipid Peroxidation; Malondialdehyde; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress | 2016 |
Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Mexico; Multiple Sclerosis, Relapsing-Remitting; Nitrates; Nitrites; Oxidative Stress; Young Adult | 2009 |